Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics
Abstract Background L-type amino acid transporter 1 (LAT1) is overexpressed in various cancers; therefore, radiohalogen-labeled amino acid derivatives targeting LAT1 have emerged as promising candidates for cancer radiotheranostics. However, 211At-labeled amino acid derivatives exhibit instability a...
Saved in:
Main Authors: | Yuta Kaizuka (Author), Hiroyuki Suzuki (Author), Tadashi Watabe (Author), Kazuhiro Ooe (Author), Atsushi Toyoshima (Author), Kazuhiro Takahashi (Author), Koichi Sawada (Author), Takashi Iimori (Author), Yoshitada Masuda (Author), Takashi Uno (Author), Kento Kannaka (Author), Tomoya Uehara (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vivo stable 211At-labeled prostate-specific membrane antigen-targeted tracer using a neopentyl glycol structure
by: Hiroyuki Suzuki, et al.
Published: (2024) -
Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies
by: Hiroyuki Suzuki, et al.
Published: (2024) -
Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial
by: Sadahiro Naka, et al.
Published: (2024) -
Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology
by: Panagiotis Kanellopoulos, et al.
Published: (2024) -
Comparative analysis of palmitoylation sites of serotonin (5‐HT) receptors in vertebrates
by: Toshie Kaizuka, et al.
Published: (2018)